Thrive Capital is executing a strategic capital return to its limited partners by distributing a significant portion of its Oscar Health holdings. On September 18, 2026, funds affiliated with or advised by Thrive Capital Management, LLC distributed approximately 6.3 million shares of Oscar Health Class A common stock. This move allows Thrive to return value to investors in Thrive Capital Partners II, L.P., Thrive Capital Partners III, L.P., and Claremount TW, L.P. after a holding period exceeding 14 years. The transaction is structured as an in-kind distribution rather than a traditional market sale of company shares.
Thrive Capital In-Kind Share Distribution
The distribution of approximately 6.3 million Class A shares represents a targeted method for Thrive Capital to return capital to its limited partners following a long-term investment cycle. According to the company, this action does not constitute a sale of Oscar Health shares by Thrive Capital or Joshua Kushner, the founder and CEO of Thrive Capital and Co-Founder and Vice Chair of Oscar Health. Kushner characterized the move as an appropriate time to return a small portion of the investment through an in-kind distribution, citing Oscar Health's execution. Crucially, Kushner stated he has no plans to sell any Oscar common stock held in his personal capacity. This distinction is vital for market participants monitoring potential selling pressure from major stakeholders. The distribution follows a holding period of more than 14 years, marking a significant milestone in the lifecycle of the initial investment made by the venture firm.
Oscar Health Voting Power and Control
Despite the distribution of Class A shares, the underlying control structure of Oscar Health remains largely intact. Following the transaction, individuals and funds affiliated with or advised by Thrive Capital, including Joshua Kushner, continue to hold a dominant position in the company's governance. The firm's collective holdings now include approximately 4.7 million Class A shares and approximately 32.9 million shares of Class B common stock. This combined position represents approximately 67% of the total voting power of Oscar’s outstanding common stock. Joshua Kushner will maintain his current roles as Vice Chairman and controlling shareholder, signaling a continued commitment to the company's long-term objectives. The company is positioning this distribution as a way to reward limited partners while maintaining the stability of its leadership and controlling interest. This allows the majority stakeholder to manage fund liquidity requirements without liquidating its core strategic position in the consumer healthcare marketplace.
Key Takeaways
- Thrive Capital distributed approximately 6.3 million shares of Oscar Health Class A common stock to its limited partners on September 18, 2026.
- The distribution includes limited partners from Thrive Capital Partners II, L.P., Thrive Capital Partners III, L.P., and Claremount TW, L.P.
- Thrive Capital and Joshua Kushner retain approximately 67% of the combined voting power of Oscar’s outstanding common stock.
FinanceInsyte's Take
In our view, this transaction is a sophisticated liquidity event designed to satisfy limited partner demands without triggering the market volatility typically associated with a major stakeholder exit. By utilizing an in-kind distribution rather than a direct sale, Thrive Capital avoids the immediate downward price pressure of a massive block trade. This move signals that while the fund is maturing and returning capital from a 14-year vintage, the conviction in Oscar Health's long-term trajectory remains high. For institutional investors, the retention of 67% voting power is the most critical metric, as it ensures that the strategic direction and governance of the company will not undergo a sudden or destabilizing shift.
Questions & Answers
How does this distribution affect the voting control of Oscar Health?
The distribution does not fundamentally alter the control structure. Thrive Capital and Joshua Kushner still collectively own approximately 4.7 million Class A shares and 32.9 million Class B shares, representing roughly 67% of the company's total voting power.
Is this a signal that Thrive Capital is exiting its position in Oscar Health?
Not necessarily. The company stated this is an in-kind distribution to return capital to limited partners after a 14-year holding period, and Joshua Kushner explicitly stated he has no plans to sell his personal holdings and remains committed to the company.
Which specific funds are receiving the distributed shares?
The shares are being distributed to the limited partners of Thrive Capital Partners II, L.P., Thrive Capital Partners III, L.P., and Claremount TW, L.P.
What is the primary mechanism used for this capital return?
The capital is being returned via an in-kind distribution of approximately 6.3 million Class A common shares, rather than a cash sale of the company's stock.
Source: OscarHealth.com
